Screener
LeMaitre Vascular LMAT Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | (unaudited) / June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $26,625 | $28,244 |
| Short-term marketable securities | 349,615 | 330,876 |
| Accounts receivable, net of allowances of $1,327 at June 30, 2026 and $1,400 at December 31, 2025 | 35,682 | 33,610 |
| Inventory and other deferred costs | 70,503 | 70,422 |
| Prepaid expenses and other current assets | 5,872 | 5,080 |
| Total current assets | 488,297 | 468,232 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's cash & equivalents?
- LeMaitre Vascular (LMAT) reported cash & equivalents of $26.63M in Q2 2026.
- How has LeMaitre Vascular's cash & equivalents changed year-over-year?
- LeMaitre Vascular's cash & equivalents decreased by 2.0% year-over-year, from $27.18M to $26.63M.
- What is the long-term trend for LeMaitre Vascular's cash & equivalents?
- Over 5 years (2020 to 2025), LeMaitre Vascular's cash & equivalents has grown at a 1.1% compound annual growth rate (CAGR), from $26.76M to $28.24M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about LeMaitre Vascular's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude